ResearcherGuiyang Medical UniversityActive in the last 2 years
Guangyu Chen
Matched on ORCID iD 0000-0003-2873-640X; OpenAlex author ID A5100654881. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2020: 3 papers · 2021: 6 papers · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 14
- Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model. Co-author DOI 10.1016/j.canlet.2025.217751↗
- FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. Co-author DOI 10.1158/0008-5472.can-23-3638↗
- Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Co-author DOI 10.1007/s13402-023-00836-3↗
- Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. Co-author DOI 10.1093/bjs/znac375↗
- HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway. Co-author DOI 10.1002/mc.23420↗
- CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13402-020-00569-7↗
- Targeting hypoxic tumor microenvironment in pancreatic cancer. Co-author DOI 10.1186/s13045-020-01030-w↗
- Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.709669↗
- Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.596573↗
- The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells. Co-author DOI 10.3390/cells10030497↗
- Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis. Last author DOI 10.3892/etm.2021.10576↗
- The enhancement of glycolysis regulates pancreatic cancer metastasis. Co-author DOI 10.1007/s00018-019-03278-z↗
- Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory. Co-author DOI 10.1186/s12935-020-1147-9↗
- Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Co-author DOI 10.1186/s12943-020-01169-7↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taiping Zhang · 12 shared papers, 2020–2025 · strength 1.71
- Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Gang Yang · 12 shared papers, 2020–2025 · strength 1.65
- Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Fangyu Zhao · 10 shared papers, 2020–2023 · strength 1.29
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signa… DOI 10.1002/mc.23420↗
- Lei You · 9 shared papers, 2020–2025 · strength 1.17
- Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
- Paper HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signa… DOI 10.1002/mc.23420↗
- Paper Targeting hypoxic tumor microenvironment in pancreatic cancer. DOI 10.1186/s13045-020-01030-w↗
- Jinxin Tao · 7 shared papers, 2021–2025 · strength 1.13
- Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Yupei Zhao · 8 shared papers, 2020–2023 · strength 1.04
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signa… DOI 10.1002/mc.23420↗
- Paper Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic… DOI 10.3389/fcell.2021.709669↗
- Yueze Liu · 7 shared papers, 2020–2024 · strength 1.00
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Jiangdong Qiu · 6 shared papers, 2021–2025 · strength 0.89
- Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signa… DOI 10.1002/mc.23420↗
- Jiangdong Qiu · 5 shared papers, 2020–2024 · strength 0.70
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. DOI 10.3389/fonc.2021.596573↗
- Wenhao Luo · 5 shared papers, 2020–2024 · strength 0.66
- Paper FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. DOI 10.1158/0008-5472.can-23-3638↗
- Paper Targeting hypoxic tumor microenvironment in pancreatic cancer. DOI 10.1186/s13045-020-01030-w↗
- Paper Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. DOI 10.3389/fonc.2021.596573↗
- Zhe Cao · 4 shared papers, 2020–2023 · strength 0.50
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. DOI 10.1007/s13402-020-00569-7↗
- Paper The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells. DOI 10.3390/cells10030497↗
- Jianchun Xiao · 3 shared papers, 2021–2023 · strength 0.40
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. DOI 10.1007/s13402-020-00569-7↗
- Paper The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells. DOI 10.3390/cells10030497↗
- Jinshou Yang · 3 shared papers, 2020–2021 · strength 0.35
- Paper Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. DOI 10.3389/fonc.2021.596573↗
- Paper The enhancement of glycolysis regulates pancreatic cancer metastasis. DOI 10.1007/s00018-019-03278-z↗
- Paper Metabolism of pancreatic cancer: paving the way to better anticancer strategies. DOI 10.1186/s12943-020-01169-7↗
- Dan Su · 2 shared papers, 2022–2023 · strength 0.31
- Paper Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic can… DOI 10.1007/s13402-023-00836-3↗
- Paper HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signa… DOI 10.1002/mc.23420↗
- Hua Huang · 2 shared papers, 2021–2023 · strength 0.28
- Bo Ren · 2 shared papers, 2020 · strength 0.23
- Bo Xu Ren · 1 shared paper, 2025 · strength 0.21
- Hao Chen · 1 shared paper, 2025 · strength 0.21
- Xinqi Li · 1 shared paper, 2025 · strength 0.21
- Jin Gu · 1 shared paper, 2025 · strength 0.21
- Yu-Pei Zhao · 1 shared paper, 2025 · strength 0.21
- Ruobing Wang · 1 shared paper, 2024 · strength 0.20
- Yuanyang Wang · 1 shared paper, 2024 · strength 0.20
- Dan Su · 1 shared paper, 2024 · strength 0.20
- Gang Yang · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.